Featured Articles
|
|
5 Ways To Avoid Cell Culture Contamination
By Bionique
Cell culture research and engineering have greatly impacted human health, ranging from vaccine manufacturing to stem cell therapies, cell-based assays, and cancer immunotherapeutic products. Critical to the success of these applications is the quality of the cultures used. The following article offers suggestions on management and protection of your cultures.
|
|
|
BridgeSourcing: A Fast, Flexible Alternative To Conventional CMO Outsourcing
By Xcellerex
For many developers of new biologics, outsourcing clinical or commercial manufacturing with a CMO makes good sense. Dozens of capable CMOs offer ready capacity to companies who can't afford the time, capital or risk involved in building their own biomanufacturing capacity.
|
|
|
|
Spotlight On Biopharmaceutical Manufacturing
|
|
Tech Note: Innovative Features Of Bio-Rad® InPlace™ Chromatography Columns Simplify Packing Procedures For Any Media Type
The Bio-Rad InPlace process chromatography columns are designed for flexibility to suit packing needs at pilot and manufacturing scale. Every type of media, from soft, highly compressible resin to rapidly settling, rigid, noncompressible beads, benefit from the unique InPlace column design.
|
|
|
Brochure: GS Gene Expression System™
The GS Gene Expression System™ uses a robust viral promoter and selection via glutamine metabolism to provide rapid development of high-yielding and stable mammalian cell lines.
|
|
|
Licensing FAQs: Freedom™ CHO-S™ Cells & Freedom™ DG44 Cells
Read more about the Freedom Licensing FAQs and answers to the questions.
|
|
|
Datasheet: Biopharmaceutical Contract Manufacturing
From having developed over 46 biopharmaceutical
products, Patheon has extensive experience ranging
from early formulation development through to product
commercialization.
|
|
|
White Paper: The Scientific Path To Cycle Development
Management of medication delivery through lyophilization — freeze-drying — is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins, and monoclonal antibodies, must be lyophilized as these therapeutic agents are insufficiently stable for ready-to-use solution dosage forms.
|
|
|
|
|
Featured Webinar
|
Membrane Cleaning In The Biopharmaceutical Industry
Free "Membrane Cleaning" Webinar:
Wednesday, November 9
1 PM EST
Learn why, when, and how to clean filter membranes. Q&A to follow.
Register online.
|
|
|
|
|
|
|
|
